Steven Snapinn

15.2k citations
110 papers · 10.7k · 2 hit papers · h-index 33

Impact in

  • Nephrology top 0.1%
    • Chronic Kidney Disease and Diabetes
    • Dialysis and Renal Disease Management
    • Blood Pressure and Hypertension Studies
    • Renin-Angiotensin System Studies
    • Heart Failure Treatment and Management
    • Cardiovascular Function and Risk Factors

Papers in

Steven Snapinn

107 papers receiving 10.1k citations

Steven Snapinn's Hit Papers

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol 2002 · 1.1k citations
1.1k0+8+16Years since publication10002.0k3.0k4.0k5.0k

Peers

Steven Snapinn
Comparison fields: 5 of 157
  • Nephrology 2.4k
  • Cardiology and Cardiovascular Medicine 4.8k
  • Endocrinology, Diabetes and Metabolism 2.9k
  • Statistics and Probability 587
  • Transplantation 91
Replace Shahnaz Shahinfar with:
Shahnaz Shahinfar United States
Sharon Anderson United States
K. Borch‐Johnsen Denmark
Mihai Gheorghiade United States
Richard H. Grimm United States
Hans‐Henrik Parving Denmark
Mikhail Kosiborod United States
Brian Claggett United States
David Fitchett Canada
Odd Erik Johansen United States
Steven Snapinn relative to Shahnaz Shahinfar United States Shahnaz Shahinfar's profile →
Citations per field
00.5×8.6×
Shahnaz Shahinfar · 1×
Citations per year

Countries citing papers authored by Steven Snapinn

Since Specialization
Citations

This map shows the geographic impact of Steven Snapinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Snapinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Snapinn more than expected).

Fields of papers citing papers by Steven Snapinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Snapinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Snapinn. The network helps show where Steven Snapinn may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven Snapinn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven Snapinn Line = papers co-authored together Steven Snapinn links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Hit paper breakdown →
20015436
2
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Hit paper breakdown →
20021090
3 2003419
4 2002362
5 2002304
6 2003198
7 2005189
8 2000181
9 1999159
10 2006153
11 2007120
12 200491
13
A comparison of methodologies in detection of the anaerobic threshold.
199082
14 200580
15 200675
16 200274
17 200473
18
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
200170
19 200066
20 200666

About Steven Snapinn

Steven Snapinn is a scholar working on Statistics and Probability, Cardiology and Cardiovascular Medicine, Economics and Econometrics, Management Science and Operations Research and Statistics, Probability and Uncertainty, having authored 110 papers that have together received 10.7k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (41 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers), Advanced Causal Inference Techniques (14 papers), Blood Pressure and Hypertension Studies (11 papers), Optimal Experimental Design Methods (11 papers), Statistical Methods and Inference (10 papers), Meta-analysis and systematic reviews (9 papers) and Statistical Methods and Bayesian Inference (9 papers). The work is most often cited by research in Nephrology (2.4k citations), Cardiology and Cardiovascular Medicine (4.8k citations), Endocrinology, Diabetes and Metabolism (2.9k citations), Statistics and Probability (587 citations) and Transplantation (91 citations). Steven Snapinn has collaborated with scholars based in United States, Sweden and Denmark. Frequent co-authors include Barry M. Brenner, Shahnaz Shahinfar, Dick de Zeeuw, William F. Keane, William E. Mitch, Giuseppe Remuzzi, Mark E. Cooper, Hans‐Henrik Parving, Qi Jiang and Jonathan M. Edelman. Their work appears in journals such as Statistics in Medicine, Statistics in Biopharmaceutical Research, Circulation, Pharmaceutical Statistics and The American Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact